Literature DB >> 15888762

ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of soft tissue sarcomas.

S Leyvraz1, S Jelic.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888762     DOI: 10.1093/annonc/mdi830

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

Review 1.  The histological variants of liposarcoma: predictive MRI findings with prognostic implications, management, follow-up, and differential diagnosis.

Authors:  Magda Rizer; Adam D Singer; Mark Edgar; Jean Jose; Ty K Subhawong
Journal:  Skeletal Radiol       Date:  2016-05-21       Impact factor: 2.199

2.  Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

Authors:  Martee L Hensley; John A Blessing; Robert Mannel; Peter G Rose
Journal:  Gynecol Oncol       Date:  2008-06       Impact factor: 5.482

Review 3.  [Surgical therapy of abdominal and trunk soft tissue sarcomas].

Authors:  S Schimmack; M W Büchler; J Weitz
Journal:  Chirurg       Date:  2009-03       Impact factor: 0.955

4.  Improved prognosis in soft-tissue sarcoma of extremity and trunk wall.

Authors:  Mika M Sampo; Katariina Klintrup; Erkki J Tukiainen; Tom O Böhling; Carl P Blomqvist
Journal:  Acta Orthop       Date:  2016-06-20       Impact factor: 3.717

5.  Patterns of Perioperative Treatment and Survival of Localized, Resected, Intermediate- or High-Grade Soft Tissue Sarcoma: A 2000-2017 Netherlands Cancer Registry Database Analysis.

Authors:  Milan Van Meekeren; Marta Fiocco; Vincent K Y Ho; Judith V M G Bovée; Hans Gelderblom; Rick L Haas
Journal:  Sarcoma       Date:  2021-07-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.